NCT00440219

Brief Summary

This study aims to determine if a short course of oral prednisone helps to improve the operative field and ease of surgery by minimizing bleeding during nasal polypectomy surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Nov 2010

Typical duration for phase_3

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 26, 2007

Completed
3.7 years until next milestone

Study Start

First participant enrolled

November 1, 2010

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

January 10, 2014

Status Verified

January 1, 2014

Enrollment Period

2.1 years

First QC Date

February 22, 2007

Last Update Submit

January 8, 2014

Conditions

Keywords

Nasal polypsSteroidsPrednisoneNasal polypectomyBlood loss, surgical

Outcome Measures

Primary Outcomes (3)

  • Intraoperative blood loss. Wormald Surgical Field Grading Scale

    This is an 11-point validated scale designed to provide a standardized method of documenting bleeding in endoscopic sinus surgery \[Athanasiadis et al., 2007\]. In addition blood loss during the surgery will be calculated from the suction canisters after accounting for the amount of irrigation used.

    Intraoperative

  • Visibility and easy of surgery

    The surgeon will assess visibility and easy of surgery during the surgery and the technical difficulty of the surgery using two visual analogue scale questions.

    Immediate Postoperative period

  • Endoscopic assessment

    The Peri-Operative Sinus Endoscopy (POSE) scoring system (total score) will be used to assess the condition of the patients' sinus cavities and the Lindholdt scale will be used to provide objective measures of polyp recurrence size based on the percent obstruction of the nasal cavity and obstruction based on anatomic location.

    4 weeks, 3 months, 6 months

Secondary Outcomes (1)

  • Quality of life survey (SNOT22)

    2 weeks, 4 weeks, 3 months, 6 months post-op

Study Arms (2)

Prednisone group

EXPERIMENTAL

Prednisone 50 mg daily for 10 days immediately pre-op

Drug: Oral Prednisone

Placebo group

PLACEBO COMPARATOR

Placebo pill for 10 days immediately pre-operative

Drug: Placebo comparator

Interventions

Prednisone 50 mg once daily for 10 days pre-op

Also known as: steroids, corticosteroids
Prednisone group

Placebo pill identical to Prednisone 10 days once daily pre-op

Also known as: sugar pill
Placebo group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients with severe obstructing nasal polyps scheduled for surgery.

You may not qualify if:

  • Patient unable to tolerate side effects of prednisone
  • Uncontrolled diabetes mellitus
  • Hypertension
  • Previous congestive heart failure
  • Acute/chronic systemic infection
  • History of hypersensitivity to prednisone
  • History of cataracts or glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mount Sinai Hospital, University of Toronto

Toronto, Ontario, M5G 1X5, Canada

Location

St. Joseph's Health Centre

Toronto, Ontario, M6R 1B5, Canada

Location

Related Publications (5)

  • O'Driscoll BR, Kalra S, Wilson M, Pickering CA, Carroll KB, Woodcock AA. Double-blind trial of steroid tapering in acute asthma. Lancet. 1993 Feb 6;341(8841):324-7. doi: 10.1016/0140-6736(93)90134-3.

    PMID: 8094111BACKGROUND
  • Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D, Kette F. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol. 2006 Jul;118(1):128-33. doi: 10.1016/j.jaci.2006.03.012. Epub 2006 May 19.

    PMID: 16815148BACKGROUND
  • Johansson L, Akerlund A, Holmberg K, Melen I, Stierna P, Bende M. Evaluation of methods for endoscopic staging of nasal polyposis. Acta Otolaryngol. 2000 Jan;120(1):72-6. doi: 10.1080/000164800760370873.

    PMID: 10779190BACKGROUND
  • Sieskiewicz A, Olszewska E, Rogowski M, Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during functional endoscopic sinus surgery in patients with severe nasal polyposis: a preliminary investigation. Ann Otol Rhinol Laryngol. 2006 Jul;115(7):490-4. doi: 10.1177/000348940611500702.

    PMID: 16900802BACKGROUND
  • Athanasiadis T, Beule A, Embate J, Steinmeier E, Field J, Wormald PJ. Standardized video-endoscopy and surgical field grading scale for endoscopic sinus surgery: a multi-centre study. Laryngoscope. 2008 Feb;118(2):314-9. doi: 10.1097/MLG.0b013e318157f764.

    PMID: 17989575BACKGROUND

MeSH Terms

Conditions

Nasal PolypsBlood Loss, Surgical

Interventions

PrednisoneSteroidsAdrenal Cortex HormonesSugars

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsHemorrhagePathologic ProcessesIntraoperative Complications

Intervention Hierarchy (Ancestors)

PregnadienediolsPregnadienesPregnanesFused-Ring CompoundsPolycyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone AntagonistsCarbohydrates

Study Officials

  • Ian Witterick, MD FRCSC

    University of Toronto Department of Otolaryngology-Head and Neck Surgery

    PRINCIPAL INVESTIGATOR
  • Randy M Leung, BSc MD

    University of Toronto Department of Otolaryngology-Head and Neck Surgery

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Otolaryngologist Head-Neck Surgeon

Study Record Dates

First Submitted

February 22, 2007

First Posted

February 26, 2007

Study Start

November 1, 2010

Primary Completion

December 1, 2012

Study Completion

June 1, 2013

Last Updated

January 10, 2014

Record last verified: 2014-01

Locations